Pulmonary function test results of two patients without GVHD who had decreased pulmonary function after transplantation for sickle cell disease
Patient No. . | Baseline . | Post-BMT . | ||||||
---|---|---|---|---|---|---|---|---|
FEV/FVC . | FVC (%) . | TLC (%) . | RV (%) . | FEV/FVC . | FVC (%) . | TLC (%) . | RV (%) . | |
5 | — | 72 | 83 | 125 | 0.47 | 63 | 79 | 143 |
16 | 0.96 | 91 | — | — | 0.89 | 79 | — |
Patient No. . | Baseline . | Post-BMT . | ||||||
---|---|---|---|---|---|---|---|---|
FEV/FVC . | FVC (%) . | TLC (%) . | RV (%) . | FEV/FVC . | FVC (%) . | TLC (%) . | RV (%) . | |
5 | — | 72 | 83 | 125 | 0.47 | 63 | 79 | 143 |
16 | 0.96 | 91 | — | — | 0.89 | 79 | — |
BMT = bone marrow transplantation; FVC = forced vital capacity; FEV/FVC = the ratio of forced expiratory volume to FVC; RV = residual volume; GVHD = raft-versus-host-disease; TLC = total lung capacity.